1 Thase ME. Treatment-resistant depression: prevalence, risk factors, and treatment strategies. J Clin Psychiatry 2011; 72: e18.
2 Fried EI, Epskamp S, Nesse RM, Tuerlinckx F, Borsboom D. What are ‘good’ depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis. J Affect Disord 2016; 189: 314–320.
3 Zhang K, Zhu Y, Zhu Y, Wu S, Liu H, Zhang W et al. Molecular, Functional, and Structural Imaging of Major Depressive Disorder. Neurosci Bull 2016; 32: 273–285.
4 Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1155–1163.
5 Fonseka TM, MacQueen GM, Kennedy SH. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder. J Affect Disord 2018; 233: 21–35.
6 Tastevin M, Richieri R, Boyer L, Fond G, Lançon C, Guedj E. Brain PET metabolic substrate of TMS response in pharmaco-resistant depression. Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation 2020; 13: 683–685.
7 Fitzgerald PB, Laird AR, Maller J, Daskalakis ZJ. A Meta-Analytic Study of Changes in Brain Activation in Depression. Hum Brain Mapp 2008; 29: 683–695.
8 Amen DG, Krishnamani P, Meysami S, Newberg A, Raji CA. Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging. J Alzheimers Dis 2017; 57: 253–266.
9 Tastevin M, Baumstarck K, Groppi F, Cermolacce M, Lagrange G, Lançon C et al. Double cone coil rTMS efficacy for treatment-resistant depression: A prospective randomized controlled trial. Brain Stimul 2019. doi:10.1016/j.brs.2019.09.009.
10 First Michael B, Williams Janet B.W, Spitzer Robert L., Gibbon Miriam. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT. 2007.
11 Bennabi D, Aouizerate B, El-Hage W, Doumy O, Moliere F, Courtet P et al. Risk factors for treatment resistance in unipolar depression: a systematic review. J Affect Disord 2015; 171: 137–141.
12 Buckman JEJ, Underwood A, Clarke K, Saunders R, Hollon SD, Fearon P et al. Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis. Clin Psychol Rev 2018; 64: 13–38.
13 Serafini G, Nebbia J, Cipriani N, Conigliaro C, Erbuto D, Pompili M et al. Number of illness episodes as predictor of residual symptoms in major depressive disorder. Psychiatry Res 2018; 262: 469–476.
14 Bennabi D, Charpeaud T, Yrondi A, Genty J-B, Destouches S, Lancrenon S et al. Clinical guidelines for the management of treatment-resistant depression: French recommendations from experts, the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental. BMC Psychiatry 2019; 19. doi:10.1186/s12888-019-2237-x.
15 Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH et al. WORK GROUP ON MAJOR DEPRESSIVE DISORDER. 2010; : 152.
16 Ruhé HG, van Rooijen G, Spijker J, Peeters FPML, Schene AH. Staging methods for treatment resistant depression. A systematic review. J Affect Disord 2012; 137: 35–45.
17 Richieri R, Boyer L, Faget-Agius C, Farisse J, Mundler O, Lançon C et al. Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression. Psychiatry Res 2015; 231: 134–140.
18 Bora E, Fornito A, Pantelis C, Yücel M. Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord 2012; 138: 9–18.
19 Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997; 8: 1057–1061.
20 Gong B, Naveed S, Hafeez DM, Afzal KI, Majeed S, Abele J et al. Neuroimaging in Psychiatric Disorders: A Bibliometric Analysis of the 100 Most Highly Cited Articles. J Neuroimaging 2019; 29: 14–33.
21 Sliz D, Hayley S. Major Depressive Disorder and Alterations in Insular Cortical Activity: A Review of Current Functional Magnetic Imaging Research. Front Hum Neurosci 2012; 6. doi:10.3389/fnhum.2012.00323.
22 Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends in Cognitive Sciences 2000; 4: 215–222.
23 Manoliu A, Meng C, Brandl F, Doll A, Tahmasian M, Scherr M et al. Insular dysfunction within the salience network is associated with severity of symptoms and aberrant inter-network connectivity in major depressive disorder. Front Hum Neurosci 2014; 7. doi:10.3389/fnhum.2013.00930.
24 Bessette KL, Jenkins LM, Skerrett KA, Gowins JR, DelDonno SR, Zubieta J-K et al. Reliability, Convergent Validity and Time Invariance of Default Mode Network Deviations in Early Adult Major Depressive Disorder. Front Psychiatry 2018; 9. doi:10.3389/fpsyt.2018.00244.
25 Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA 2005; 102: 9673–9678.
26 Reilly P. Head injury: pathophysiology and management of severe closed injury. Chapman and Hall Medical: London, 1997.
27 Henriksen OM, Vestergaard MB, Lindberg U, Aachmann-Andersen NJ, Lisbjerg K, Christensen SJ et al. Interindividual and regional relationship between cerebral blood flow and glucose metabolism in the resting brain. J Appl Physiol 2018; 125: 1080–1089.
28 Watts ME, Pocock R, Claudianos C. Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease. Front Mol Neurosci 2018; 11. doi:10.3389/fnmol.2018.00216.
29 Voineskos D, Daskalakis ZJ, Blumberger DM. Management of Treatment-Resistant Depression: Challenges and Strategies. Neuropsychiatr Dis Treat 2020; 16: 221–234.
30 Holtzmann J, Richieri R, Saba G, Allaïli N, Bation R, Moliere F et al. [How to define treatment-resistant depression?]. Presse Med 2016; 45: 323–328.
31 Gronemann FH, Jorgensen MB, Nordentoft M, Andersen PK, Osler M. Socio-demographic and clinical risk factors of treatment-resistant depression: A Danish population-based cohort study. J Affect Disord 2020; 261: 221–229.